Jennifer K. Litton, MD
Disclosures: Grant or research support-Pfizer, Inc.-|Grant or research support-EMD Serono-|Grant or research support-Genentech, Inc.-|Grant or research support-Zenith-|Grant or research support-AstraZeneca-|Speakers Bureau-Physicians Education Resource-|Speakers Bureau-MedLearning-|Speakers Bureau-Prime Oncology-|Speakers Bureau-Medscape-|Speakers Bureau-Clinical Care Options-|Speakers Bureau-Medpage-|Honoraria-San Antonio Breast Cancer Symposiuym-|Membership on advisory committees or review panels, board membership, etc.-ASCO-|Membership on advisory committees or review panels, board membership, etc.-NCCN-|Membership on advisory committees or review panels, board membership, etc.-SITC-|royalty-UptoDate- - 05/11/2021
Jennifer Keating Litton, MD is an Assistant Professor in the Department of Breast Medical Oncology as well as a faculty member in Clinical Cancer Genetics

Jennifer Keating Litton, MD is Vice President of Clinical Research and a Professor in the Department of Breast Medical Oncology at The University of Texas MD Anderson Cancer Center.  She holds an additional faculty position in the Graduate School of Biomedical Sciences at The University of Texas Health Sciences Center in Houston.  She attended Duke University, with degrees in English and in History and The University of Massachusetts Medical School.  After completing an Internal Medicine Residency at Baylor College of Medicine, she then served as Chief Medical Resident.  She completed a fellowship in Medical Oncology at The University of Texas MD Anderson Cancer Center before joining the faculty in the Department of Breast Medical Oncology.  Her research interests include the treatment of young breast cancer patients, including the treatment of breast cancer during pregnancy, treatment-related infertility, hereditary cancer syndromes, immunotherapy and triple negative breast cancer.  She has been the principle investigator for multiple clinical trials.  She served as a member of the National Cancer Center Network National Guidelines Panel for Hereditary Breast and Ovarian Cancer Syndromes and has been appointed to the Breast Immuno-Oncology Task Force of the National Cancer Institute Breast Cancer Steering Committee and Co-Chair of the Society for Immunotherapy of Cancer (SITC) Breast Cancer Subcommittee and co-Chair of the NeoSTEEP projectShe has authored multiple abstracts, peer-reviewed journal articles, and book chapters.  Dr. Litton has served on the boards of the St. Luke’s Episcopal Health Charities, the Childrens Fund, Suites of Hope and is an alumnus of the Texas Lyceum.  She lives in Houston with her husband Todd and their three children.